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Adult human beings, as a group, possess a relatively high degree of 
humoral  immunity  against  the  pneumococcus.  This  property  of 
blood is a  specific one, since it has been shown that individuals may 
vary greatly in their pneumococcidal activity against the different 
types (i--4).  Little is known, however, concerning the constancy of 
this reaction of the blood of individuals of any particular age group. 
Ward  1 (2), who has made a few observations on this point, states that 
he noted no change in the titer of humoral immune substances in nine 
normal persons on whom pneumococcidal tests were  repeated.  No 
details were given in these instances as to the actual time interval 
elapsing between tests.  That  changes in  the  titer  of  the immune 
substances do occur under normal circumstances is suggested by the 
studies of Sutliff and Finland  (4),  who found that the incidence of 
pneumococcidal power in human beings varies with age.  In rabbits 
Woo (5)  has  shown  that  the  titer  of  antipneumococcal substances 
increases with the age of the animal. 
The  present  investigation was  undertaken to  study the  relative 
constancy of the degree of humoral immunity  found in the individuals 
of the adult age group. 
Materials  and Methods 
Pneumococcidal Tests.--These were carried out according to the technique de- 
scribed  by Robertson and his coworkers (6,  7), employing quantitated mixtures 
of serum, washed leucocytes, and pneumococci in sealed tubes, which were agitated 
i Ward (2) retested one individual, from whom 40 to 50 cc. of blood bad been 
withdrawn at frequent intervals over a period of 2 to 3 months, and found a diminu- 
tion in mount of humoral immunity against Types I, II and III pneumococci. 
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during  incubation.  Human  leucocytes  were  obtained  from  Group  I  (Jansky) 
donors. 
The organisms used in the tests were laboratory strains  of Type I and Type II 
pneumococci  which  had  been  kept  at  maximum mouse  virulence  by frequent 
animal  passage since originally  isolated.  Preceding  each group of tests  animal 
passage was repeated.  0.1 cc. of a 10 -r dilution of a broth culture of each organ- 
ism killed mice in repeated  tests in from 24 to 36 hours. 
Five dilutions  of a standard suspension of these organisms  (10  -z to 10 -7 dilu- 
tions of a suspension containing  approximately  one billion pairs of pneumococci) 
were added to the tubes containing the mixture of leucocytes and test serum.  The 
actual number of organisms in each dilution was estimated  from the colony count 
of plates  seeded with 0.1 cc. of the 10 -~ dilution  (theoretically  to contain 100 or- 
ganisms).  Actually,  the number of organisms found varied between  21 and 200 
per 0.1  cc. of the suspension.  This  divergence  of colony counts is  taken  into 
consideration  in the following manner. 
The counts in the 10 -~ dilution of the Type I series varied between 75 and 200, 
and in the Type II series between 13 and 220.  It so happened that all of the Type 
II series with colony counts below 68 showed pneumococcidal activity in the tube 
containing the 10 -7 dilution.  For this reason all cases in both Type I and Type II 
series could conveniently be grouped  within  the range of colony counts of 68 to 
220, which would thus include  the range of colony counts in the Type I  series. 
The difference between the lowest and highest colony counts in the 10 -~ dilutions 
in which growth occurred in the two series is thus equivalent  to a 3.2 dilution. 
It has been found that the pneumococcidal tests as carried out in this study are 
accurate only within one 10-fold dilution.  Consequently,  a difference in pneumo- 
coccidal power in repeated tests equivalent to a single 10-fold dilution is disregarded 
as within the limits of error of the method.  To facilitate  comparison of the tests 
with divergent  colony counts a 3-fold dilution is also disregarded.  Consequently, 
to exceed what we have thus established  as experimental  variation,  there  must 
occur a difference in pneumococcidal power, expressed in terms of the number of 
organisms killed,  equivalent  to a  300-fold dilution. 
Cases Selected for Study  ~ 
Thirty-four individuals,  22 to 40 years of age, in good health,  who 
were  employed in  various  capacities  in  the  Albert  Merritt  Billings 
Hospital,  were first tested in  1931  in  the latter half of the month of 
September and throughout the month of October.  During this time 
nine members of the group of thirty-four developed a  common cold, 
and  serum  specimens  obtained  at  the  time  of maximum  symptoms 
Four of these cases gave a history of pneumonia 5 or more years previous to the 
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were retested for comparison with their pneumococcidal power during 
the normal period.  All of the group of thirty-four individuals were 
retested during March and April of 1932. 
Twelve cases  of a  severe influenza-like infection occurring in epi- 
demic form among the students of the University of Chicago were 
chosen  for  another  series.  Their  ages  varied  between  20  and  35 
years.  The clinical course of this infection was similar in all cases. 
There were 3  to  4  days of  temperature ranging from  100-104°F., 
marked malaise, generalized aching of muscles, mild sore throat, head- 
ache, and often a harsh, unproductive cough.  There were no abnor- 
mal physical signs in the chest.  The white blood cell counts ranged 
between 3,900 and  6,800.  Blood  samples  for  the  pneumococcidal 
tests were obtained in most instances at the time of the highest tem- 
perature, or a day or so thereafter.  The first series of determinations 
were made in  February,  1932.  6  to  8  weeks later,  after complete 
convalescence, a second blood sample was similarly tested.  All pneu- 
mococcidal determinations were made within 1 to 2 days after pro- 
curing the blood samples. 
Changes in Humoral Immunity in Normal Individuals 
The results of the pneumococcidal tests of the thirty-four normal 
individuals are given in Table I.  It is seen that about one-third of 
the individuals possessed  no humoral immunity against the Type I 
pneumococcus, while only one case lacked this property against the 
Type II.  A majority of the members of the series showed relatively 
high  immunity  against  Pneumococcus Type  II.  With  a  similar 
technique Sufliff and Finland (4)  and Ward  (2)  have demonstrated 
this same relative difference in pneumococcidal activity against these 
two types. 
Considering a change of 300-fold dilution as significant in evaluating 
this data we found seven individuals who showed a decrease in pneu- 
mococcidal activity against Type I  pneumococcus.  Only two cases 
of diminished humoral immunity occurred against Type II.  No in- 
crease in  pneumococcidal power was  found in  this  series.  Of  the 
seven individuals showing decreased pneumococcidal power toward 
Type I,  two also  had a  decrease in activity toward Type II.  The 
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TABLE  I 
Pneumococcidal Promoting Activity of the Serum of Normal Individuals 
Individuals 
1.  Po 
2.  Ed 
3. Wa 
4. Ma 
5.  Sm 
6.  Ca 
7.  Sa 
8.  Ha 
9.  Or 
10.  Re 
11.  Ke 
12.  Ch 
13. Ro 
14.  Hi 
15.  Fr 
16.  Gi 
17.  Ri 
18.  Da 
19. He 
20.  Pa 
21.  Se 
22.  Sa 
23.  Ha 
24.  Ha 
25.  Br 
26.  St 
27. Ro 
28.  Ki 
29. J.H. 
30.  Re 
31.  Fr 
32.  Ma 
33.  V.S. 
34.  M.H. 
Type I pneumococcus 
No. killed 
Fall, 1931  Spring~  1932 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
200  0 
91  0 
126  0 
1,530  0 
1,530  680 
1,530  0680 
19,800 
Change in 
titer of serum 
immune 
substances 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Dim. 
0 
0 
Dim. 
Type II pneumococcus 
No. killed 
Fall,  1931  Spring, 1932 
220,000  28,000 
144,000  44,000 
14,400  52,000 
70,000  5,200 
7,000  28,000 
74,000  52,000 
680  186 
680,000  130,000 
0  0 
220  1,860 
23,000  28,000 
74,000  13,000 
68,000  130,000 
140,000  540 
1,400  520 
140,000  52,000 
1,440,000  130,000 
19,800 
19,800 
126,000 
126,000 
15,300 
15,300 
20,000 
91,000 
1,980,000 
78,000 
2,000,000 
1,980,000 
15,300 
91,000 
1,260,000 
15,300 
780,000 
8,100 
8,100 
0 
0 
14,500 
80,000 
76,000 
81,000 
6,800 
8,000 
8,000 
760,000 
80,000 
81,000 
800,000 
0 
680,000 
0 
0 
Dim. 
Dim. 
0 
0 
0 
0 
Dim. 
0 
Dim. 
0 
0 
0 
0 
Dim. 
0 
1,440,000 
144,000 
68,000 
68,000 
140,000 
140,000 
7,000 
74,000 
1,440,000 
7,400 
7O 
1,440,000 
14,000 
74,000 
680,000 
1,400 
7,400 
44,000 
28,000 
44,000 
44,000 
186,000 
280,000 
130,000 
44,000 
520,0O0 
2,800 
0 
130,000 
54,000 
44,000 
28,000 
0 
5,200 
Change in 
titer of serum 
immune 
substances 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Dim. 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Dim. 
0 
In the tables, dim. indicates diminished; incr., increased. 
II pneumococcus.  The majority of cases showed no particular change 
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series  of tests.  It is to be noted that the number of microorganisms 
killed  in the spring tests  in individual instances tended to be less  than 
in the fall, although the difference did not exceed the 300-fold dilution. 
One possible reason for this may have been that the colony counts in 
the respective dilutions happened to be lower in the spring tests. 
Examination  of the data  in the Type I  series on the basis of the 
dilution at which growth occurred rather  than the number of micro- 
organisms  killed  gives the  same contrast  between the  two  series of 
tests.  No  change  occurred  in  twenty-eight  cases.  Four  showed  a 
drop in titer of three dilutions, three of two dilutions, and five of one 
dilution.  Three cases showed an increase in pneumococcidal activity 
equivalent  to one dilution. 
Another point to note is the fact that decrease in titer of pneumo- 
coccidal power  for  one  type was  not  necessarily  associated  with  a 
change  in  reaction  toward  the other type. 
Effect of Colds 
In the series of nine individuals  tested while suffering from colds, 
five  exhibited  a  definite  change  in  pneumococcidal  power  of their 
blood  (Table  II).  One  showed  a  decrease  against  Type  I  but  no 
alteration in reaction toward Typa II.  Of the four cases with altered 
reaction  toward Type II pneumococci,  two showed an increase,  and 
two a  decrease.  In none of these instances was there any change in 
their  reaction  toward  the  other organism. 
At least fourteen of the thirty-four normal persons mentioned above 
had  colds  in  the  interval  between  the  two  sets  of pneumococcidal 
tests.  Three of these were among those showing diminution in pneu- 
mococcidal titer.  Three other cases in the normal series with a similar 
alteration  in their degree of immunity were free of colds throughout 
the period covered by these tests. 
There was thus no uniform response to colds, and we are inclined 
to interpret these findings as having no relation to the cold itself but 
to  represent  fluctuations  due  to  some  other  cause.  It  is  seen,  for 
instance,  in Cases 5, 6, and 8, that the change was a  gradual one and 
not an abrupt reaction to the cold.  8 
3 The first two tests in eight of the cases were made at intervals of 1 to 3 weeks. 
In the ninth  case 7 weeks elapsed between the normal test and the "cold" test. 
The last determinations were made from 5 to 6 months after the initial ones. 250  ANTIPNEUMOCOCCAL HUMORAL  IMMUNITY 
TABLE  II 
Pneumococcidal Promoting Activity of the Serum of Subjects Having Colds 
Ind/vlduals 
1.  Fe 
2.  Gr 
3.  Sc 
4.  St 
5.  Co 
6.  Mi 
7.  Co 
8.  Ei 
Type I  pneumococcus 
Change  in 
No. killed  titer of 
serum 
Normal  Cold  Normal  immune 
substances 
Fall, 1931  Fail,  1931 
1,980  0 
780,000 2,000,000 
200  0 
168  0 
0  0* 
0  0 
780,000 1,740,000 
9,100  1,740 
Spring, 
1932 
76 
81,000 
0 
0 
0 
0 
580,000 
1,300 
Dim. 
0 
0 
0 
0 
0 
0 
0 
Type II pneumococcus 
No. killed 
Cold  Normal 
Fall., 193 l 
1,440 
74,000 
70,000 
2,500 
220,000 I 
74,000 
740 
Fall, 1931 
2,200 
7,000 
25,000 
2,500 
70,000* 
25,000 
2,200,000 
20,000 
Normal 
Spring, 
1932 
13,000 
44,000 
54,000 
4,400 
280 
186 
520,000 
520,000 
Change in 
titer of 
serum 
immune 
substances 
0 
0 
0 
Inc. 
Dim. 
Dim. 
0 
Inc. 
* In this case the test during the cold preceded the first test when patient was 
normal. 
TABLE  III 
Pneumococcidal Promoting Activity  of the Serum  of Patients  with Influenza-Like 
Infection 
Individuals 
1.  Ha 
2.  Sc 
3.  Cl 
4.  Be 
5.  Bu 
6.  Sh 
7.  Jo 
8.  Mo 
9.  As 
10.  Re 
11.  Ba 
12.  F1 
Type I  pneumococcus 
No. killed 
Influenza-like  Normal* 
infection* 
0  0 
0  0 
0  0 
0  0 
0  8O 
0  0 
97,000  80 
97,000  130,000 
0  0 
600  0 
600,000  1,450,000 
60,000  14,500 
Change in 
titer of 
serum 
immune 
substances 
0 
0 
0 
0 
0 
0 
Dim. 
0 
0 
Dim. 
0 
0 
Type II pneumococcus 
No. killed 
Influenza-like- 
infection*  Normal* 
0  5,400 
0  0 
4,900  5,200 
6,300  1,860 
4,900  54,000 
63,000  54,000 
0  0 
4,900  52,000 
4,900  18,600 
6,300  52,000 
6,300  18,600 
630,000  18,600 
Change in 
titer of 
serum 
immune 
substances 
Inc. 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
* 6 to 8 weeks elapsed between the two series of tests. JAMES  B.  GRAESER  AND  M.  CORNWELL  HARRISON  251 
Effect of Influenza-Like Infection 
Nine of the twelve cases tested showed no change in the pneumo- 
coccidal promoting power of their serum (Table III).  In two cases 
(Nos. 7 and 10) there was a decrease in this serum property forPneu- 
mococcus Type I, and in one (Case 1) an increase for Type II.  These 
tests were done  about 2 months apart in the spring of 1932.  Here 
again we note no uniform change in titer as a result of this influenza- 
like upper respiratory infection. 
DISCUSSION 
There are certain limitations to the use of pneumococcidal tests for 
this type of study, although the method is ideally adapted for measur- 
ing the relative pneumococcidal activity of different blood  samples 
when  tested  simultaneously.  In  such  experiments  the  serum-leu- 
cocyte mixtures,  the state of the microorganism, and  the dilutions 
of the standard pneumococcus suspension are identical for each speci- 
men.  In the present experiments the tests in the several serum sam- 
ples of each individual were done at different times which may have 
introduced variations in the constituents of the test.  The most likely 
variable would seem to be the possible occurrence of changes in the 
virulence of the pneumococcus used.  While pathogenicity for animals 
was maintained by frequent passage, we cannot be certain that maxi- 
mum virulence for human beings is preserved by this means.  Thus 
the possibility cannot be dismissed that some, if not all, of the changes 
noted  in  the pneumococcidal activity of adult  serum were  due  to 
biological variations in the pneumococci used in the tests.  However, 
if this were the only explanation of the observed differences we should 
have expected a uniform reaction of all individuals to this one factor. 
Actually, the majority of individuals showed no change in the degree 
of the pneumococcidal promoting activity of their serum.  On several 
of the persons in this series we have data from pneumococcidal tests 
done 1 to  2 years previously with precisely the same technique and 
the same strains of Type I and Type II pneumococci.  One individual 
(No. 23.  Ha, Table I), tested in 1929, had no Type I pneumococcidal 
substances in  her blood, although in  1931 she had a  high degree of 
immunity against  this  organism.  This  particular  person  had  been 252  ANTIPNEUM'OCOCCAL  HUM'ORAL  IMMUNITY 
working in  the laboratory with  Type I  pneumococci during these 
intervening years.  In the same period no change in pneumococcidal 
activity toward Pneumococcus Type II had occurred.  Three other 
individuals  tested  in  1930 with  the  same  strains  have  shown  no 
change in  their degree of immunity toward these  organisms.  The 
data presented in  this paper  is  insufficient to  permit any detailed 
analysis of the possible  factors concerned in  the changes which we 
have noted.  One might suspect from the studies here reported that 
seasonal variation was a  factor.  The tests done in the fall of 1931 
were made on individuals in good health who had had the usual ad- 
vantages of summer outdoor activities.  These same subjects in the 
subsequent months were closely confined indoors during the daylight 
hours  by  their  duties  about  the  hospital.  However,  an  adequate 
evaluation of this or any other factor would involve a protracted study 
over a period Of years of a large group of people. 
SUMM~.RY 
Fifty-five individuals were tested to determine the pneumococcidal 
promoting activity of their serum against Types I and II pneumococci. 
By repeated tests an attempt was made to study the constancy of the 
degree of their immunity over intervals of 2 to 6 months.  In this 
group were included nine persons with common colds and twelve cases 
of  a  severe influenza-like infection.  Fifteen of  the  fifty-five cases 
showed a  change in titer of their humoral immunity against either 
Type I or Type II or both.  Three of these showed an increase, and 
twelve a decrease.  This reaction in most instances was a specific one 
in that the altered reaction toward one type was not associated with a 
similar  change  toward  the  other  type  pneumococcus.  Colds  and 
influenza-like infections apparently exerted no effect upon the titer 
of humoral immune substances. 
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